Zostavax lawsuit claims center on a shingles vaccine that some patients say caused the very illness it promised to prevent. This litigation targets Merck & Co., the maker of Zostavax. Thousands of people filed suit after developing shingles or other injuries. The cases were consolidated into a federal multidistrict litigation, or MDL. This page explains the history, current status, and what the litigation means for affected patients in 2026.
Case Timeline
Last checked: September 03, 2026
What Is the Zostavax Lawsuit About?
Zostavax is a “zoster vaccine live,” approved by the FDA on May 25, 2006. It was a live-attenuated vaccine, meaning it used a weakened form of the varicella-zoster virus. Merck marketed it to prevent shingles in older adults. However, plaintiffs allege the weakened live virus reactivated in some people. As a result, they say it caused shingles instead of preventing it.
The core zostavax lawsuit claim is straightforward. Plaintiffs argue Merck knew during premarket trials that the vaccine could cause shingles. Yet Merck allegedly failed to warn patients and doctors. Reports indicate shingles was not added as a listed side effect until December 2014. That was roughly seven years after approval. Plaintiffs say this delay left patients unaware of the risk.
The injuries alleged go beyond shingles itself. For example, plaintiffs report vision loss, hearing loss, and Bell’s palsy. Others describe nerve pain, autoimmune disorders, and neurological problems. Some claims involve heart complications. Zostavax is no longer sold in the United States. It was discontinued in November 2020, replaced by the newer vaccine Shingrix.
MDL Case Status and Key Facts
| MDL Detail | Current Data |
|---|---|
| MDL Number | MDL-2848 |
| Pending Cases | 826 |
| Presiding Judge | Harvey Bartle, III |
| Federal District | PAE |
| Data Source | U.S. Judicial Panel on Multidistrict Litigation |
| Last Updated | August 03, 2026 |
The federal cases were centralized into MDL-2848. Judge Harvey Bartle, III oversees the litigation. The MDL sits in the Eastern District of Pennsylvania. This structure lets one judge manage shared pretrial issues efficiently. The table below summarizes the key facts.
| Detail | Information |
|---|---|
| MDL Number | MDL-2848 |
| Case Name | In re: Zostavax (Zoster Vaccine Live) Products Liability Litigation |
| Presiding Judge | Hon. Harvey Bartle, III |
| Federal District | Eastern District of Pennsylvania (PAE) |
| Defendant | Merck & Co., Inc. |
| Approximate Active Cases | 826 (as of December 2025) |
| Bellwether Trials | None reached verdict; MDL effectively closed |
The zostavax lawsuit MDL faced a major setback over causation. Judge Bartle issued a “Lone Pine” order for the largest group of cases. These were the “Group A” cases. Group A plaintiffs claimed the vaccine gave them shingles. The court required proof through a specific DNA test. That test, called a PCR test, could tell the vaccine strain apart from the natural virus.
Many plaintiffs could not meet this standard. Typically, PCR testing must happen during an active shingles outbreak. Most patients had long recovered by the time they filed suit. As a result, the court dismissed many claims. On appeal, the Third Circuit affirmed the dismissal of roughly 1,189 cases in July 2024. The panel agreed PCR testing was the only reliable method.
Who Qualifies for the Zostavax Lawsuit?
Eligibility for a zostavax lawsuit depends heavily on the type of injury. The vaccine was given mostly to adults age 50 and older. Anyone who received Zostavax between 2006 and 2020 may have a claim. However, the injury type matters more than ever after the court rulings.
Shingles-only claims face steep hurdles now. Those “Group A” cases largely collapsed without PCR proof. In contrast, claims involving other serious injuries may still have footing. For example, vision loss, hearing loss, and neurological damage are treated differently. These non-shingles injuries were the “Group B” cases in the MDL.
Evidence remains essential for any potential claim. You typically need proof you received Zostavax. Medical records showing the injury and its timing help. A qualified attorney can review whether PCR results or other testing exist. In most cases, an early case review costs nothing. Only a licensed attorney can assess your specific situation.
How to File a Zostavax Lawsuit Claim
Filing starts with finding an experienced attorney. Look for lawyers who handle pharmaceutical and product liability cases. Many offer free consultations. They will review your vaccination records and medical history. For example, they check dates, diagnoses, and any lab testing you had.
If your case moves forward, you may complete a plaintiff fact sheet. This document details your exposure and injuries. It is a standard step in MDL litigation. Your attorney handles the court filings and deadlines. Given that the federal MDL is winding down, some claims may proceed in state court instead.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
The statute of limitations is critical. Each state sets its own deadline to file. These deadlines are often short, sometimes two or three years. As a result, waiting can permanently bar your claim. If you believe Zostavax harmed you, act quickly. A licensed attorney can confirm the deadline that applies to you.
Settlement Updates and What to Expect
There is no global settlement in the zostavax lawsuit MDL. Merck has not agreed to a settlement fund. Instead, the litigation has moved through dismissals and appeals. Following the Third Circuit ruling, the federal MDL is effectively closed. This outcome disappointed many plaintiffs.
No bellwether trial reached a verdict for plaintiffs. Bellwether trials are test cases used to gauge value. Because causation failed early, the cases never got that far. For example, the DNA testing requirement ended most shingles claims before trial. This is unusual compared to many other pharmaceutical MDLs.
What affects any remaining payout varies. Factors include injury severity, medical costs, and available proof of causation. Typically, stronger evidence supports a stronger claim. However, no compensation is guaranteed in these cases. You may qualify only if your facts and evidence fit the narrow surviving categories. An attorney can give you a realistic assessment.
State-by-State Considerations
State law shapes what remains of this litigation. With the federal MDL closed, some plaintiffs pursue claims in state courts. State tort reform laws can affect damages caps and filing deadlines. For example, states like California, Texas, Florida, Pennsylvania, and New York had notable plaintiff activity. Each state applies its own rules on causation and evidence.
These differences matter for strategy and outcome. In most cases, your state of residence or vaccination determines where you file. Some states have longer statutes of limitations than others. As a result, two similar injuries can have very different legal paths. A local attorney can explain how your state’s guides and laws apply to your situation.
Frequently Asked Questions
Is the Zostavax MDL still accepting new cases?
The federal MDL is effectively closed after the Third Circuit affirmed dismissals. New shingles-only claims face severe causation hurdles. However, some non-shingles injury claims may proceed in state court. Consult a licensed attorney about your options.
Why were so many Zostavax cases dismissed?
The court required PCR (DNA) testing to prove the vaccine caused shingles. That test must occur during an active outbreak. Most plaintiffs could not provide it. As a result, the “Group A” shingles cases were largely dismissed.
How much is a Zostavax claim worth?
The value varies widely and depends on injury type and evidence. There is no settlement fund and no guaranteed compensation. Payouts, if any, hinge on proof of causation. Only an attorney can evaluate your specific claim.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- U.S. Judicial Panel on Multidistrict Litigation (JPML)
- U.S. Department of Justice
- FDA Safety Alerts & Recalls
- Centers for Disease Control and Prevention
- U.S. Environmental Protection Agency
Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Texas Tort Reform Guide
- California Tort Reform Guide
- Georgia Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.